TriSalus Life Sciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $24.0M
Liabilities Breakdown FY2024
Total Liabilities: $49.9M
Asset Breakdown
Total Assets: $24.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $8.5M | 35.6% |
| Accounts Receivable | $5.1M | 21.2% |
| Inventory | $4.0M | 16.9% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $6.3M | 26.3% |
Liabilities Breakdown
Total Liabilities: $49.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.3M | 4.6% |
| Long-Term Debt | $22.1M | 44.3% |
| Other Liabilities | $25.5M | 51.2% |